| 45.44 Data as of May 24 |  -1.15 / -2.47%Today’s Change | 32.51 Today|||52-Week Range 48.00 | +33.02% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $73.8B |
Company Description
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease, ulcerative colitis, and complications associated with chronic kidney disease, among other indications. It also has a pipeline of new medicines, including various compounds or indications in Phase II or Phase III development across such medical specialties as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. The company was founded on April 10, 2012 and is headquartered in North Chicago, IL.
Employees
Shareholders
| Other institutional | 39.12% |
| Mutual fund holders | 30.44% |
| Individual stakeholders | 0.08% |
Top Executives
| Richard A. Gonzalez | Chairman & Chief Executive Officer |
| Azita Saleki-Gerhardt, PhD | Senior Vice President-Operations |
| William J. Chase | Chief Financial Officer & Executive Vice President |
| John M. Leonard, MD | Chief Scientific Officer & Senior Vice President |
| Thomas A. Hurwich | Chief Accounting Officer, VP & Controller |
.
